nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—SLC12A1—blood plasma—acquired immunodeficiency syndrome	0.0148	0.0484	CbGeAlD
Hydroflumethiazide—CA1—nerve—acquired immunodeficiency syndrome	0.0135	0.044	CbGeAlD
Hydroflumethiazide—CA4—nerve—acquired immunodeficiency syndrome	0.0105	0.0344	CbGeAlD
Hydroflumethiazide—CA1—blood plasma—acquired immunodeficiency syndrome	0.0102	0.0333	CbGeAlD
Hydroflumethiazide—CA7—digestive system—acquired immunodeficiency syndrome	0.00762	0.0249	CbGeAlD
Hydroflumethiazide—KCNMA1—retina—acquired immunodeficiency syndrome	0.00735	0.024	CbGeAlD
Hydroflumethiazide—CA9—digestive system—acquired immunodeficiency syndrome	0.00669	0.0218	CbGeAlD
Hydroflumethiazide—CA2—blood plasma—acquired immunodeficiency syndrome	0.00661	0.0216	CbGeAlD
Hydroflumethiazide—SLC12A3—lung—acquired immunodeficiency syndrome	0.00624	0.0204	CbGeAlD
Hydroflumethiazide—CA14—spinal cord—acquired immunodeficiency syndrome	0.00583	0.019	CbGeAlD
Hydroflumethiazide—SLC12A1—blood—acquired immunodeficiency syndrome	0.00543	0.0177	CbGeAlD
Hydroflumethiazide—Cramp muscle—Nelfinavir—acquired immunodeficiency syndrome	0.00527	0.0076	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Didanosine—acquired immunodeficiency syndrome	0.00524	0.00755	CcSEcCtD
Hydroflumethiazide—SLC12A1—spinal cord—acquired immunodeficiency syndrome	0.00523	0.0171	CbGeAlD
Hydroflumethiazide—Pancreatitis—Nevirapine—acquired immunodeficiency syndrome	0.00512	0.00738	CcSEcCtD
Hydroflumethiazide—Vasculitis—Lamivudine—acquired immunodeficiency syndrome	0.00511	0.00736	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00496	0.00715	CcSEcCtD
Hydroflumethiazide—CA12—digestive system—acquired immunodeficiency syndrome	0.00495	0.0162	CbGeAlD
Hydroflumethiazide—Pancreatitis—Stavudine—acquired immunodeficiency syndrome	0.00494	0.00713	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Abacavir—acquired immunodeficiency syndrome	0.00487	0.00702	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Didanosine—acquired immunodeficiency syndrome	0.00483	0.00697	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Delavirdine—acquired immunodeficiency syndrome	0.00476	0.00687	CcSEcCtD
Hydroflumethiazide—ATP1A1—retina—acquired immunodeficiency syndrome	0.00472	0.0154	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Nevirapine—acquired immunodeficiency syndrome	0.00471	0.00679	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00468	0.00675	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Nelfinavir—acquired immunodeficiency syndrome	0.00456	0.00658	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Stavudine—acquired immunodeficiency syndrome	0.00455	0.00656	CcSEcCtD
Hydroflumethiazide—Jaundice—Nevirapine—acquired immunodeficiency syndrome	0.00454	0.00654	CcSEcCtD
Hydroflumethiazide—CA7—brain—acquired immunodeficiency syndrome	0.00451	0.0147	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Abacavir—acquired immunodeficiency syndrome	0.00448	0.00646	CcSEcCtD
Hydroflumethiazide—Purpura—Delavirdine—acquired immunodeficiency syndrome	0.00442	0.00638	CcSEcCtD
Hydroflumethiazide—SLC12A1—nervous system—acquired immunodeficiency syndrome	0.00441	0.0144	CbGeAlD
Hydroflumethiazide—Jaundice—Nelfinavir—acquired immunodeficiency syndrome	0.00439	0.00634	CcSEcCtD
Hydroflumethiazide—Jaundice—Stavudine—acquired immunodeficiency syndrome	0.00438	0.00632	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Nevirapine—acquired immunodeficiency syndrome	0.00434	0.00626	CcSEcCtD
Hydroflumethiazide—KCNMA1—lung—acquired immunodeficiency syndrome	0.00431	0.0141	CbGeAlD
Hydroflumethiazide—Pancreatitis—Zidovudine—acquired immunodeficiency syndrome	0.0043	0.00619	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Indinavir—acquired immunodeficiency syndrome	0.00425	0.00612	CcSEcCtD
Hydroflumethiazide—SLC12A1—central nervous system—acquired immunodeficiency syndrome	0.00424	0.0139	CbGeAlD
Hydroflumethiazide—CA5B—blood—acquired immunodeficiency syndrome	0.00423	0.0138	CbGeAlD
Hydroflumethiazide—ATP1A1—skin of body—acquired immunodeficiency syndrome	0.00415	0.0135	CbGeAlD
Hydroflumethiazide—CA12—lung—acquired immunodeficiency syndrome	0.00414	0.0135	CbGeAlD
Hydroflumethiazide—Pancreatitis—Indinavir—acquired immunodeficiency syndrome	0.00399	0.00576	CcSEcCtD
Hydroflumethiazide—KCNMA1—nervous system—acquired immunodeficiency syndrome	0.00399	0.013	CbGeAlD
Hydroflumethiazide—CA1—lymphoid tissue—acquired immunodeficiency syndrome	0.00397	0.013	CbGeAlD
Hydroflumethiazide—CA1—digestive system—acquired immunodeficiency syndrome	0.00392	0.0128	CbGeAlD
Hydroflumethiazide—CA5B—vagina—acquired immunodeficiency syndrome	0.00392	0.0128	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00389	0.00561	CcSEcCtD
Hydroflumethiazide—KCNMA1—central nervous system—acquired immunodeficiency syndrome	0.00384	0.0125	CbGeAlD
Hydroflumethiazide—Cramp muscle—Delavirdine—acquired immunodeficiency syndrome	0.00384	0.00553	CcSEcCtD
Hydroflumethiazide—CA12—nervous system—acquired immunodeficiency syndrome	0.00383	0.0125	CbGeAlD
Hydroflumethiazide—Jaundice—Zidovudine—acquired immunodeficiency syndrome	0.00381	0.00549	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Efavirenz—acquired immunodeficiency syndrome	0.00377	0.00544	CcSEcCtD
Hydroflumethiazide—CA14—brain—acquired immunodeficiency syndrome	0.00375	0.0122	CbGeAlD
Hydroflumethiazide—CA1—blood—acquired immunodeficiency syndrome	0.00374	0.0122	CbGeAlD
Hydroflumethiazide—CA5B—lung—acquired immunodeficiency syndrome	0.00371	0.0121	CbGeAlD
Hydroflumethiazide—CA12—central nervous system—acquired immunodeficiency syndrome	0.00369	0.012	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Indinavir—acquired immunodeficiency syndrome	0.00368	0.0053	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Zidovudine—acquired immunodeficiency syndrome	0.00365	0.00526	CcSEcCtD
Hydroflumethiazide—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.00362	0.00522	CcSEcCtD
Hydroflumethiazide—CA2—retina—acquired immunodeficiency syndrome	0.00362	0.0118	CbGeAlD
Hydroflumethiazide—CA1—bone marrow—acquired immunodeficiency syndrome	0.00362	0.0118	CbGeAlD
Hydroflumethiazide—Pancreatitis—Delavirdine—acquired immunodeficiency syndrome	0.00361	0.00521	CcSEcCtD
Hydroflumethiazide—CA1—spinal cord—acquired immunodeficiency syndrome	0.0036	0.0117	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Ritonavir—acquired immunodeficiency syndrome	0.0036	0.00519	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Ritonavir—acquired immunodeficiency syndrome	0.00355	0.00512	CcSEcCtD
Hydroflumethiazide—Jaundice—Indinavir—acquired immunodeficiency syndrome	0.00354	0.00511	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Efavirenz—acquired immunodeficiency syndrome	0.00351	0.00507	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Efavirenz—acquired immunodeficiency syndrome	0.00347	0.00501	CcSEcCtD
Hydroflumethiazide—Anorexia—Amprenavir—acquired immunodeficiency syndrome	0.00345	0.00498	CcSEcCtD
Hydroflumethiazide—CA5B—nervous system—acquired immunodeficiency syndrome	0.00344	0.0112	CbGeAlD
Hydroflumethiazide—Cramp muscle—Saquinavir—acquired immunodeficiency syndrome	0.00342	0.00492	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Nelfinavir—acquired immunodeficiency syndrome	0.00339	0.00488	CcSEcCtD
Hydroflumethiazide—SLC12A1—brain—acquired immunodeficiency syndrome	0.00337	0.011	CbGeAlD
Hydroflumethiazide—ATP1A1—lymphoid tissue—acquired immunodeficiency syndrome	0.00336	0.011	CbGeAlD
Hydroflumethiazide—Jaundice—Efavirenz—acquired immunodeficiency syndrome	0.00335	0.00482	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Ritonavir—acquired immunodeficiency syndrome	0.00334	0.00482	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Delavirdine—acquired immunodeficiency syndrome	0.00332	0.00479	CcSEcCtD
Hydroflumethiazide—ATP1A1—digestive system—acquired immunodeficiency syndrome	0.00332	0.0108	CbGeAlD
Hydroflumethiazide—CA5B—central nervous system—acquired immunodeficiency syndrome	0.00331	0.0108	CbGeAlD
Hydroflumethiazide—CA1—lung—acquired immunodeficiency syndrome	0.00328	0.0107	CbGeAlD
Hydroflumethiazide—Cramp muscle—Lamivudine—acquired immunodeficiency syndrome	0.00326	0.0047	CcSEcCtD
Hydroflumethiazide—Agitation—Nelfinavir—acquired immunodeficiency syndrome	0.00324	0.00467	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.00323	0.00466	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Saquinavir—acquired immunodeficiency syndrome	0.00321	0.00463	CcSEcCtD
Hydroflumethiazide—Jaundice—Delavirdine—acquired immunodeficiency syndrome	0.0032	0.00462	CcSEcCtD
Hydroflumethiazide—CA2—skin of body—acquired immunodeficiency syndrome	0.00318	0.0104	CbGeAlD
Hydroflumethiazide—ATP1A1—blood—acquired immunodeficiency syndrome	0.00316	0.0103	CbGeAlD
Hydroflumethiazide—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00315	0.00455	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.00315	0.00454	CcSEcCtD
Hydroflumethiazide—Anorexia—Didanosine—acquired immunodeficiency syndrome	0.00315	0.00454	CcSEcCtD
Hydroflumethiazide—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.00314	0.00453	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.00311	0.00448	CcSEcCtD
Hydroflumethiazide—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.00311	0.00448	CcSEcCtD
Hydroflumethiazide—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.0031	0.00447	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Ritonavir—acquired immunodeficiency syndrome	0.00307	0.00443	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Lamivudine—acquired immunodeficiency syndrome	0.00307	0.00442	CcSEcCtD
Hydroflumethiazide—CA4—digestive system—acquired immunodeficiency syndrome	0.00307	0.01	CbGeAlD
Hydroflumethiazide—ATP1A1—bone marrow—acquired immunodeficiency syndrome	0.00306	0.00998	CbGeAlD
Hydroflumethiazide—KCNMA1—brain—acquired immunodeficiency syndrome	0.00305	0.00996	CbGeAlD
Hydroflumethiazide—ATP1A1—spinal cord—acquired immunodeficiency syndrome	0.00304	0.00994	CbGeAlD
Hydroflumethiazide—CA1—nervous system—acquired immunodeficiency syndrome	0.00303	0.0099	CbGeAlD
Hydroflumethiazide—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.00299	0.00431	CcSEcCtD
Hydroflumethiazide—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.00296	0.00427	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.00296	0.00426	CcSEcCtD
Hydroflumethiazide—KCNMA1—lymph node—acquired immunodeficiency syndrome	0.00295	0.00963	CbGeAlD
Hydroflumethiazide—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.00294	0.00423	CcSEcCtD
Hydroflumethiazide—ATP1A1—vagina—acquired immunodeficiency syndrome	0.00293	0.00956	CbGeAlD
Hydroflumethiazide—CA12—brain—acquired immunodeficiency syndrome	0.00293	0.00955	CbGeAlD
Hydroflumethiazide—CA4—blood—acquired immunodeficiency syndrome	0.00292	0.00953	CbGeAlD
Hydroflumethiazide—CA1—central nervous system—acquired immunodeficiency syndrome	0.00292	0.00953	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.00291	0.00419	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.00287	0.00414	CcSEcCtD
Hydroflumethiazide—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.00285	0.00411	CcSEcCtD
Hydroflumethiazide—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.00283	0.00408	CcSEcCtD
Hydroflumethiazide—CA4—bone marrow—acquired immunodeficiency syndrome	0.00283	0.00922	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.00282	0.00407	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00282	0.00406	CcSEcCtD
Hydroflumethiazide—CA4—spinal cord—acquired immunodeficiency syndrome	0.00281	0.00918	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00281	0.00405	CcSEcCtD
Hydroflumethiazide—ATP1A1—lung—acquired immunodeficiency syndrome	0.00277	0.00904	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00276	0.00399	CcSEcCtD
Hydroflumethiazide—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00274	0.00395	CcSEcCtD
Hydroflumethiazide—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.00274	0.00395	CcSEcCtD
Hydroflumethiazide—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00273	0.00394	CcSEcCtD
Hydroflumethiazide—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.00273	0.00394	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.00273	0.00394	CcSEcCtD
Hydroflumethiazide—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.00272	0.00392	CcSEcCtD
Hydroflumethiazide—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.00269	0.00388	CcSEcCtD
Hydroflumethiazide—CA5B—brain—acquired immunodeficiency syndrome	0.00263	0.00857	CbGeAlD
Hydroflumethiazide—Agitation—Indinavir—acquired immunodeficiency syndrome	0.00261	0.00376	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.0026	0.00375	CcSEcCtD
Hydroflumethiazide—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.0026	0.00375	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00258	0.00372	CcSEcCtD
Hydroflumethiazide—CA2—lymphoid tissue—acquired immunodeficiency syndrome	0.00257	0.0084	CbGeAlD
Hydroflumethiazide—ATP1A1—nervous system—acquired immunodeficiency syndrome	0.00257	0.00837	CbGeAlD
Hydroflumethiazide—CA4—lung—acquired immunodeficiency syndrome	0.00256	0.00836	CbGeAlD
Hydroflumethiazide—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00255	0.00368	CcSEcCtD
Hydroflumethiazide—CA2—digestive system—acquired immunodeficiency syndrome	0.00254	0.0083	CbGeAlD
Hydroflumethiazide—CA5B—lymph node—acquired immunodeficiency syndrome	0.00254	0.00828	CbGeAlD
Hydroflumethiazide—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.0025	0.0036	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.00249	0.00359	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00248	0.00357	CcSEcCtD
Hydroflumethiazide—ATP1A1—central nervous system—acquired immunodeficiency syndrome	0.00247	0.00806	CbGeAlD
Hydroflumethiazide—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.00247	0.00356	CcSEcCtD
Hydroflumethiazide—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.00247	0.00355	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.00245	0.00354	CcSEcCtD
Hydroflumethiazide—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00245	0.00353	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00244	0.00352	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00243	0.00351	CcSEcCtD
Hydroflumethiazide—CA2—blood—acquired immunodeficiency syndrome	0.00242	0.0079	CbGeAlD
Hydroflumethiazide—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00241	0.00347	CcSEcCtD
Hydroflumethiazide—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.00237	0.00342	CcSEcCtD
Hydroflumethiazide—CA4—nervous system—acquired immunodeficiency syndrome	0.00237	0.00774	CbGeAlD
Hydroflumethiazide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00237	0.00342	CcSEcCtD
Hydroflumethiazide—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.00236	0.0034	CcSEcCtD
Hydroflumethiazide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00236	0.0034	CcSEcCtD
Hydroflumethiazide—CA2—bone marrow—acquired immunodeficiency syndrome	0.00234	0.00765	CbGeAlD
Hydroflumethiazide—CA2—spinal cord—acquired immunodeficiency syndrome	0.00233	0.00762	CbGeAlD
Hydroflumethiazide—CA1—brain—acquired immunodeficiency syndrome	0.00232	0.00757	CbGeAlD
Hydroflumethiazide—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00231	0.00332	CcSEcCtD
Hydroflumethiazide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.0023	0.00332	CcSEcCtD
Hydroflumethiazide—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.0023	0.00331	CcSEcCtD
Hydroflumethiazide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00228	0.00329	CcSEcCtD
Hydroflumethiazide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00228	0.00329	CcSEcCtD
Hydroflumethiazide—CA4—central nervous system—acquired immunodeficiency syndrome	0.00228	0.00745	CbGeAlD
Hydroflumethiazide—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00228	0.00329	CcSEcCtD
Hydroflumethiazide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00228	0.00329	CcSEcCtD
Hydroflumethiazide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00228	0.00328	CcSEcCtD
Hydroflumethiazide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00227	0.00327	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00227	0.00327	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00226	0.00326	CcSEcCtD
Hydroflumethiazide—CA2—vagina—acquired immunodeficiency syndrome	0.00224	0.00733	CbGeAlD
Hydroflumethiazide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00224	0.00323	CcSEcCtD
Hydroflumethiazide—CA1—lymph node—acquired immunodeficiency syndrome	0.00224	0.00731	CbGeAlD
Hydroflumethiazide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00221	0.00318	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.0022	0.00317	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00219	0.00315	CcSEcCtD
Hydroflumethiazide—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00218	0.00314	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00217	0.00312	CcSEcCtD
Hydroflumethiazide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00215	0.0031	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00214	0.00309	CcSEcCtD
Hydroflumethiazide—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00213	0.00307	CcSEcCtD
Hydroflumethiazide—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00213	0.00307	CcSEcCtD
Hydroflumethiazide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00213	0.00307	CcSEcCtD
Hydroflumethiazide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00212	0.00306	CcSEcCtD
Hydroflumethiazide—CA2—lung—acquired immunodeficiency syndrome	0.00212	0.00693	CbGeAlD
Hydroflumethiazide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00212	0.00305	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00211	0.00304	CcSEcCtD
Hydroflumethiazide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.0021	0.00303	CcSEcCtD
Hydroflumethiazide—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.0021	0.00303	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.0021	0.00302	CcSEcCtD
Hydroflumethiazide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00209	0.00301	CcSEcCtD
Hydroflumethiazide—Rash—Didanosine—acquired immunodeficiency syndrome	0.00208	0.003	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00208	0.003	CcSEcCtD
Hydroflumethiazide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00208	0.003	CcSEcCtD
Hydroflumethiazide—Headache—Didanosine—acquired immunodeficiency syndrome	0.00207	0.00298	CcSEcCtD
Hydroflumethiazide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00206	0.00297	CcSEcCtD
Hydroflumethiazide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00206	0.00297	CcSEcCtD
Hydroflumethiazide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00205	0.00296	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00205	0.00296	CcSEcCtD
Hydroflumethiazide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00204	0.00295	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00203	0.00293	CcSEcCtD
Hydroflumethiazide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00203	0.00292	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00201	0.0029	CcSEcCtD
Hydroflumethiazide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.002	0.00288	CcSEcCtD
Hydroflumethiazide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00198	0.00286	CcSEcCtD
Hydroflumethiazide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00198	0.00285	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00197	0.00284	CcSEcCtD
Hydroflumethiazide—CA2—nervous system—acquired immunodeficiency syndrome	0.00197	0.00642	CbGeAlD
Hydroflumethiazide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00196	0.00283	CcSEcCtD
Hydroflumethiazide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00196	0.00283	CcSEcCtD
Hydroflumethiazide—ATP1A1—brain—acquired immunodeficiency syndrome	0.00196	0.0064	CbGeAlD
Hydroflumethiazide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00196	0.00282	CcSEcCtD
Hydroflumethiazide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00195	0.00281	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00193	0.00279	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.0019	0.00274	CcSEcCtD
Hydroflumethiazide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.0019	0.00274	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.0019	0.00273	CcSEcCtD
Hydroflumethiazide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.0019	0.00273	CcSEcCtD
Hydroflumethiazide—ATP1A1—lymph node—acquired immunodeficiency syndrome	0.00189	0.00618	CbGeAlD
Hydroflumethiazide—CA2—central nervous system—acquired immunodeficiency syndrome	0.00189	0.00618	CbGeAlD
Hydroflumethiazide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00189	0.00272	CcSEcCtD
Hydroflumethiazide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00187	0.0027	CcSEcCtD
Hydroflumethiazide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00187	0.0027	CcSEcCtD
Hydroflumethiazide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00187	0.0027	CcSEcCtD
Hydroflumethiazide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00187	0.00269	CcSEcCtD
Hydroflumethiazide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00186	0.00268	CcSEcCtD
Hydroflumethiazide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00185	0.00266	CcSEcCtD
Hydroflumethiazide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00184	0.00265	CcSEcCtD
Hydroflumethiazide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00183	0.00264	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00183	0.00263	CcSEcCtD
Hydroflumethiazide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00182	0.00263	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00182	0.00263	CcSEcCtD
Hydroflumethiazide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00181	0.00261	CcSEcCtD
Hydroflumethiazide—CA4—brain—acquired immunodeficiency syndrome	0.00181	0.00591	CbGeAlD
Hydroflumethiazide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00181	0.00261	CcSEcCtD
Hydroflumethiazide—Rash—Stavudine—acquired immunodeficiency syndrome	0.00181	0.00261	CcSEcCtD
Hydroflumethiazide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00181	0.0026	CcSEcCtD
Hydroflumethiazide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.0018	0.0026	CcSEcCtD
Hydroflumethiazide—Headache—Stavudine—acquired immunodeficiency syndrome	0.0018	0.00259	CcSEcCtD
Hydroflumethiazide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.0018	0.00259	CcSEcCtD
Hydroflumethiazide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00179	0.00258	CcSEcCtD
Hydroflumethiazide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00179	0.00258	CcSEcCtD
Hydroflumethiazide—Rash—Abacavir—acquired immunodeficiency syndrome	0.00178	0.00257	CcSEcCtD
Hydroflumethiazide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00178	0.00256	CcSEcCtD
Hydroflumethiazide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00178	0.00256	CcSEcCtD
Hydroflumethiazide—Headache—Abacavir—acquired immunodeficiency syndrome	0.00177	0.00255	CcSEcCtD
Hydroflumethiazide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00176	0.00254	CcSEcCtD
Hydroflumethiazide—CA4—lymph node—acquired immunodeficiency syndrome	0.00175	0.00572	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00174	0.00251	CcSEcCtD
Hydroflumethiazide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00174	0.00251	CcSEcCtD
Hydroflumethiazide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00171	0.00246	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00171	0.00246	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.0017	0.00246	CcSEcCtD
Hydroflumethiazide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.0017	0.00245	CcSEcCtD
Hydroflumethiazide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.0017	0.00244	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00168	0.00243	CcSEcCtD
Hydroflumethiazide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00168	0.00242	CcSEcCtD
Hydroflumethiazide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00166	0.0024	CcSEcCtD
Hydroflumethiazide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00166	0.0024	CcSEcCtD
Hydroflumethiazide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00166	0.00239	CcSEcCtD
Hydroflumethiazide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00165	0.00238	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00162	0.00234	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00161	0.00233	CcSEcCtD
Hydroflumethiazide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.0023	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00159	0.00229	CcSEcCtD
Hydroflumethiazide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00158	0.00228	CcSEcCtD
Hydroflumethiazide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00157	0.00226	CcSEcCtD
Hydroflumethiazide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00157	0.00226	CcSEcCtD
Hydroflumethiazide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00157	0.00226	CcSEcCtD
Hydroflumethiazide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00156	0.00225	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00155	0.00223	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00154	0.00223	CcSEcCtD
Hydroflumethiazide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00154	0.00222	CcSEcCtD
Hydroflumethiazide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00153	0.00221	CcSEcCtD
Hydroflumethiazide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00152	0.00219	CcSEcCtD
Hydroflumethiazide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.00217	CcSEcCtD
Hydroflumethiazide—CA2—brain—acquired immunodeficiency syndrome	0.0015	0.0049	CbGeAlD
Hydroflumethiazide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.0015	0.00216	CcSEcCtD
Hydroflumethiazide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00148	0.00214	CcSEcCtD
Hydroflumethiazide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00148	0.00213	CcSEcCtD
Hydroflumethiazide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00147	0.00212	CcSEcCtD
Hydroflumethiazide—Rash—Indinavir—acquired immunodeficiency syndrome	0.00146	0.00211	CcSEcCtD
Hydroflumethiazide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00146	0.0021	CcSEcCtD
Hydroflumethiazide—CA2—lymph node—acquired immunodeficiency syndrome	0.00145	0.00474	CbGeAlD
Hydroflumethiazide—Headache—Indinavir—acquired immunodeficiency syndrome	0.00145	0.00209	CcSEcCtD
Hydroflumethiazide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00209	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00143	0.00207	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.00206	CcSEcCtD
Hydroflumethiazide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00204	CcSEcCtD
Hydroflumethiazide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00201	CcSEcCtD
Hydroflumethiazide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.002	CcSEcCtD
Hydroflumethiazide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00139	0.002	CcSEcCtD
Hydroflumethiazide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00138	0.00199	CcSEcCtD
Hydroflumethiazide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00138	0.00199	CcSEcCtD
Hydroflumethiazide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00138	0.00198	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00198	CcSEcCtD
Hydroflumethiazide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00137	0.00198	CcSEcCtD
Hydroflumethiazide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00193	CcSEcCtD
Hydroflumethiazide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.00192	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00191	CcSEcCtD
Hydroflumethiazide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00132	0.0019	CcSEcCtD
Hydroflumethiazide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00132	0.0019	CcSEcCtD
Hydroflumethiazide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00131	0.00189	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00189	CcSEcCtD
Hydroflumethiazide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.0013	0.00187	CcSEcCtD
Hydroflumethiazide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00185	CcSEcCtD
Hydroflumethiazide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00128	0.00184	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00184	CcSEcCtD
Hydroflumethiazide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00124	0.00179	CcSEcCtD
Hydroflumethiazide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.00178	CcSEcCtD
Hydroflumethiazide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00123	0.00178	CcSEcCtD
Hydroflumethiazide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00122	0.00176	CcSEcCtD
Hydroflumethiazide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00122	0.00176	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00175	CcSEcCtD
Hydroflumethiazide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00121	0.00175	CcSEcCtD
Hydroflumethiazide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00171	CcSEcCtD
Hydroflumethiazide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.0017	CcSEcCtD
Hydroflumethiazide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00118	0.00169	CcSEcCtD
Hydroflumethiazide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00117	0.00169	CcSEcCtD
Hydroflumethiazide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00117	0.00168	CcSEcCtD
Hydroflumethiazide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00166	CcSEcCtD
Hydroflumethiazide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.00163	CcSEcCtD
Hydroflumethiazide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00112	0.00162	CcSEcCtD
Hydroflumethiazide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00112	0.00162	CcSEcCtD
Hydroflumethiazide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00161	CcSEcCtD
Hydroflumethiazide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.0016	CcSEcCtD
Hydroflumethiazide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.00152	CcSEcCtD
